Skip to main content
. 2018 Mar 6;8:55. doi: 10.1038/s41398-018-0102-1

Table 1.

Demographic and clinical characteristics of participants

Parameters Plasma (Wnt ligand) cohort Leukocyte (mRNA) cohort
SCZ (N = 551) BD (N = 246) HC (N = 639) Post hoc analysis SCZ (N = 338) BD (N = 241) HC (N = 263) Post hoc analysis
Male sex, N (%) 334 (60.6) 97 (39.4) 364 (57.0) SCZ > HC > BD 206 (60.9) 94 (39.0) 144 (54.8) SCZ > HC > BD
Ethnicity (Cauc. %) 444 (80.6) 213 (86.6) 629 (98.4) HC > BD > SCZ 165 (90.7) 141 (94.6) 208 (100) HC > BD > SCZ
Medication
Antipsychotics 510 (84.6) 167 (66.0) SCZ > BD 172 (94.5) 115 (77.2) SCZ > BD
Lithium 12 (2.0) 51 (20.2) BD > SCZ 3 (1.2) 32 (21.6) BD > SCZ
Antidepressants 179 (31.5) 95 (38.8) BD > SCZ 51 (28.0) 58 (38.9) BD > SCZ
Mood stabilizers 56 (9.3) 87 (34.4) BD > SCZ 28 (15.4) 66 (44.3) BD > SCZ
Age (years) 27 (13) 29 (18) 31 (13) BD, HC > SCZ 25 (11) 36 (20) 36.0 (11) BD, HC > SCZ
DOI (years) 4 (8) 4 (10) BD > SCZ 5 (9) 5 (13) NS
PANSS total score 62 (22) 44 (13) SCZ > BD 64 (24) 45 (14) SCZ > BD
YMRS total score 3 (9) 2 (5) SCZ > BD 5 (8) 2 (7) SCZ > BD
IDS total score 17 (19) 17 (16) NS 19 (17) 15 (17) NS
GAF-S 40 (15) 57 (16) BD > SCZ 39 (10) 54 (17) BD > SCZ
GAF-F 42 (14) 51 (19) BD > SCZ 40 (11) 50 (17) BD > SCZ

SCZ schizophrenia, BD bipolar disorder, HC healthy controls, Cauc. Caucasians, NS nonsignificant, DOI duration of illness, PANSS Positive and Negative Syndrome Scale, YMRS Young Mania Rating Scale, IDS Inventory of Depressive Symptoms, GAF-S Global Assessment of Functioning-Symptom Scale, GAF-F Global Assessment of Functioning-Function Scale

Categorical data are given as percent in brackets, while continuous data are given as median with interquartile range. Post hoc analysis is performed using Pearson chi-square for categorical data, and Mann–Whitney U-tests for continuous data